BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  Esperion to Participate in Fireside Chat at the Jefferies 2017 London Healthcare Conference

  Esperion today announced that president and chief executive officer, Tim M. Mayleben, will participate in an analyst-led fireside chat with investors at the Jefferies 2017 London Healthcare Conference in London on Thursday, November 16, 2017 at 1:20 p.m. Greenwich Mean Time / 8:20 a.m. Eastern Time.

  November 14, 2017

   · 

  3 min read
• BerGenBio to Present BGB324 and KEYTRUDA (pembrolizumab) Clinical Trial at the 2017 San Antonio Breast Cancer Symposium

  The poster presentation will describe the rationale and design of the combination study with KEYTRUDA and BGB324, a first-in-class and highly selective small molecule Axl kinase inhibitor, which is being developed to target tumour immune evasion and resistance.

  November 14, 2017

   · 

  1 min read
• ProQR Announces Proposed Public Offering of Ordinary Shares

  ProQR expects to grant the underwriters a 30-day option to purchase additional ordinary shares, on the same terms and conditions.

  November 14, 2017

   · 

  3 min read
• Drug Development

  Amarin: Vascepa (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Patients With Persistent High Triglycerides and Chronic Kidney Disease

  This oral presentation was held at the American Heart Association (AHA) 2017 Scientific Sessions in Anaheim, California.

  November 14, 2017

   · 

  8 min read
• Pharm Country

  DiamiR Announces Publication of Data on microRNA Biomarkers for Neurodegenerative Diseases in Alzheimer’s Research & Therapy

  The study reported in the publication was conducted in collaboration with researchers at Perelman School of Medicine at the University of Pennsylvania.

  November 14, 2017

   · 

  3 min read
• Business

  Imprimis Pharma Announces Third Quarter 2017 Results

  Gross ophthalmology-related revenue of $4.9M, up over 60% year-over-year.

  November 14, 2017

   · 

  15 min read
• Business

  Audentes Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

  Audentes Therapeutics today reported its financial results for the quarter ended September 30, 2017, and provided an update on the company’s recent achievements and anticipated upcoming milestones.

  November 14, 2017

   · 

  10 min read
• Business

  Aurinia Reports Third Quarter 2017 Financial Results and Provides Operational Highlights

  Cash of $182.4 million as of September 30, 2017.

  November 14, 2017

   · 

  13 min read
• Business

  GTx Provides Corporate Update and Reports Third Quarter 2017 Financial Results

  During the quarter, GTx raised net proceeds of $45.6 million in a private placement of its common stock and warrants to purchase its common stock.

  November 14, 2017

   · 

  12 min read
• Business

  NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results

  Sales of $4.1 million increased 19% year-over-year.

  November 14, 2017

   · 

  12 min read